During the past decade, G. B. Pant Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "G. B. Pant Hospital" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Govind Ballabh Pant Hospital" with 7 trials sponsored, "LIB Therapeutics LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Human Genome Sciences Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "G. B. Pant Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Indian Society of Critical Care Medicine" with 1 trials as a collaborator and "Medical Health Research Infrastructure Council, Australia" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "G. B. Pant Hospital" are "Heart Failure" (3 trials), "Hepatic Encephalopathy" (3 trials), "Migraine" (3 trials), "Chronic Hepatitis C" (2 trials) and "Episodic Migraine" (2 trials). Many other conditions were trialed in "G. B. Pant Hospital" in a lesser frequency.

Most popular intervention types in "G. B. Pant Hospital" are "Drug" (25 trials), "Other" (4 trials), "Procedure" (4 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Galcanezumab" (3 trials), "Lasmiditan" (3 trials), "Tirzepatide" (3 trials) and "lerodalcibep" (3 trials). Other intervention names were less common.

The vast majority of trials in "G. B. Pant Hospital" are 33 trials for "All" genders.

Currently, there are NaN active trials in "G. B. Pant Hospital". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in G. B. Pant Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in G. B. Pant Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".

G. B. Pant Hospital has several departments that took part in Clinical trials: "Department of Gastroenterology, G B Pant Hospital" - 7 trials